Article and Video CATEGORIES

Cancer Journey

Search By

GRACE Targeted Therapies in Lung Cancer 2021 - Liquid and Tissue Biopsies in Acquired Resistance
GRACE Targeted Therapies in Lung Cancer 2021 - Liquid and Tissue Biopsies in Acquired Resistance
Author
GRACE Videos and Articles
Image
Targeted Therapies Patient Forum 2021
The 2021 Targeted Therapies Patient Forum, presented live-online, featured top oncologists in their field discussing the most current and emerging information in targeted therapies, and answering patient questions in real-time.

For the full agenda, visit https://cancergrace.org/2021-targeted-therapies-patient-forum-agenda, and for information on the faculty, https://cancergrace.org/2021-targeted-therapies-patient-forum-faculty.  For a first glance at the full playlist of videos, visit the event on our YouTube channel. 

YOUTUBE PLAYLIST

 

In this video, the AM panel of oncologists, with Drs. Weiss, Dagogo-Jack, and Thompson discuss the challenges and use of liquid and tissue biopsies in acquired resistance.

 

A huge thank you to our sponsors! #AstraZeneca #Novartis #lilly #blueprintmedicines #takedaoncology #boehringerIngelheim #genentech

Image

AstraZeneca, Novartis, Lilly, Blueprint Medicines, Takeda Oncology, Boehringer Ingelheim, Genentech

Video Language

Next Previous link

Previous PostNext Post

Related Content

Article
The article describes the AVO treatment, a combination therapy for Chronic Lymphocytic Leukemia (CLL), particularly for high-risk patients. CLL is a slow-growing cancer where abnormal white blood cells accumulate. "High-risk" CLL refers to cases with specific genetic changes (e.g., in TP53) that make the disease harder to treat.
Image
2025 Spanish Targeted Therapy in Lung Cancer Patient Forum
Article
Da click aquí para más información y para registrarte ahora